CGIFX | VTISX | CGIFX / VTISX | |
Total Expense Ratio | 0.99 | 0.05 | 2,106% |
Annual Report Gross Expense Ratio | 0.99 | 0.05 | 2,106% |
Fund Existence | 17 years | 9 years | - |
Gain YTD | 18.991 | 15.280 | 124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17B | 493B | 3% |
Annual Yield % from dividends | 2.29 | 2.94 | 78% |
Returns for 1 year | 14.48 | 12.70 | 114% |
Returns for 3 years | 46.83 | 34.22 | 137% |
Returns for 5 years | 57.39 | 44.41 | 129% |
Returns for 10 years | 68.51 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XYLD | 38.73 | -0.12 | -0.31% |
Global X S&P 500® Covered Call ETF | |||
PPH | 90.78 | -1.00 | -1.09% |
VanEck Pharmaceutical ETF | |||
OAIM | 37.36 | -0.45 | -1.20% |
OneAscent International Equity ETF | |||
PGRO | 39.12 | -0.49 | -1.25% |
Putnam Focused Large Cap Growth ETF | |||
UGE | 18.52 | -0.41 | -2.15% |
ProShares Ultra Consumer Staples |